##
##
|Trustee name|Office (ifany)|||Dates acted if not for whole
ear|
|---|---|---|---|---|
|Ann Beasley|Chair||||
|Vanessa Ford|Acting Chief Executive|||Until September 2020|
||Chief Executive|||Since September 2020|
|Philip Murray|Director ofFinance and|Performance|||
|Sharon Spain|Acting
Director
of|Nursing|and|Until November 2020|
||Quality Standards||||
||Director
of
Nursing|and|Quality|Since November 2020|
||Standards||||
|Dr Charlotte
Harrison|Acting Medical Director|||Until March 2021|
|Dr Billy Boland|Medical Director|||Since March 2021|
|Ranjeet Kaile|Director
of
Communications||and|Until February 2021|
||Stakeholder
Engagement||||
|Jennifer Allan|Chief Operating
Officer||||
|Amy Scammell|Director ofStrategy and Commercial||||
||Development||||
|Richard
Flatman|Non-Executive
Director||||
|Jean Daintith|Non-Executive
Director||||
|Sola Afuape|Non-Executive
Director||||
|Juliet Armstrong|Non-Executive
Director||||
|Vikas Sagar|Non-Executive
Director||||
|Doreen McCollin|Non-Executive
Director||||
|Deborah
Bowman|Non-Executive
Director||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||Total|Total|
|---|---|---|---|---|---|---|
|||Note|Unrestricted
Funds|Restricted
Funds|Funds|Funds|
||||||2021|2020|
||||E'000|E'000|F'000|E'000|
|Income and endowments|from:||||||
|Donations
and legacies|||119||119||
|Charitable
activities|||||||
|Other trading
activities|||||||
|Investments|||||||
|Total incoming resources|||120||121||
|Expenditure
on:|||||||
|Charitable
activities|||||||
|Admin and Audit fees|||(12)||(12)|(8)|
|Patients
comfort 8 other|||(35)||(35)|(36)|
|Staff welfare|||(34)||(34)|(6)|
||||(81)||(81)|(50)|
|Total expenditure|||(81)||(81)|(50)|
|Net gains/(losses)
on investments||15||||(2)|
|Net income/(expenditure)|||39||40|(43)|
|Transfers
between
funds|||||||
|Net Movement
in funds|||39||40|(43)|
|Reconciliation
ofFunds|||||||
|Total Funds brought
forward||20|37|17|54|97|
|Total Funds carried forward||20||18|94|54|
##
|||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|
||Note|||||
|||Funds|Funds|Funds|Funds|
|||||2021|2020|
|||f.'000||f'000|E'000|
|Fixed assets:||||||
|Investments||23|16|39|81|
|Total Fixed Assets||23|16|39|81|
|Current assets:||||||
|Debtors|16|||||
|Cash and cash equivalents|17|177||179|34|
|Total Current Assets||177||179|34|
|Liabilities:||||||
|Creditors
falling due within
one year|18|(124)||(124)|(61)|
|Net Current
assetsl(liabilities)||53||55|(27)|
|Total assets less current
liabilities||76|18|94|54|
|Creditors
falling due after
more than one year|18|||||
|Total net assets or
liabilities||76|18|94|54|
|The funds ofthe Charity:|20|||||
|Restricted
income funds|||18|18|17|
|Unrestricted
income funds||76||76|37|
|Total Charity funds||76|18|94|54|
##
##
||||||Note|Total|Total|
|---|---|---|---|---|---|---|---|
|||||||funds|funds|
|||||||2021|2020|
|||||||f'000|F'000|
|Cash flows from operating|activities:|||||||
|Net cash provided by (used in) operating|||activities||19|143|(9)|
|Cash flows from investing|activities:|||||||
|Dividends,
interest and rents|from investments||||6|||
|Proceeds from the sale of investments|||||19|||
|Purchase ofinvestments|||||19|||
|Net cash provided by (used in)investing|||activities|||||
|Change in cash and cash
period|equivalents||in the reporting|||145|(6)|
|Gash
and
cash
equivalents
at the
reporting
period||beginning||of the||34|4Q|
|Cash and cash equivalents
period|at the end||of the reporting|||179|34|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|
|||funds|Funds|2021|2020|
|||F'000|K'000|E'000|f.'000|
|NHS Charities Together||100||100||
|Donations|from individuals|||||
|Corporate|donations|||||
|Legacies||||||
|Grants||||||
|Total||119||119||
##
|||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|
|||||funds|funds|2021|2020|
|||||K'000|K'000|K'000|K'000|
|Fixed Asset|Equity|and|similar|||||
|investments||||||||
|Short
term|Investments||8|||||
|deposits 8 cash on||deposit||||||
##
##
||||||Grant funded|Support|Total|Total|
|---|---|---|---|---|---|---|---|---|
||||||Activity|Costs|2021|2020|
||||||f.'000|f.'000|R'000|F'000|
|Patients
other|comfort,||functions|8|35||41|40|
|Staff education||and|welfare||34||40|10|
|Total|||||69|12|81|50|
##
##
##
||||Raising
funds|Charitable
activities|**2021** **T** **t**
i
o al|2020
Total|Basis|
|---|---|---|---|---|---|---|---|
||||F'000|E'000|R'000|E'000||
|Independent||Examination||2|2|2|Expenditure|
|Accountancy||Costs|||||Expenditure|
|Staff salary||recharges||10|10|6|Expenditure|
|Governance||costs||12|12|||
|Office Admin||Charge||||||
|Total||||12|12|||
||||Unrestricted
funds|Restricted
funds|Endowment
funds||2020|
|||||||Total|Total|
||||R'000|R'000|R'000|R'000|R'000|
|Charitable|Activities||12|||12|8|
||||12|||12|8|
##
##
##
##
##
|16. Analysis of|current debtors|||
|---|---|---|---|
|Debtors under|1year|2021|2020|
|||f.000|OOOO|
|Accrued income||||
|Total||||
|17. Analysis of|cash and cash equivalents|||
|||2021|2020|
|||f000|f000|
|Cashin hand||1|1|
|Current Account||178|33|
|Total cash and|cash equivalents|179|34|
|No cash orcash equivalents|orcurrent asset investments|orcurrent asset investments|orcurrent asset investments|orcurrent asset investments|were held in non-cash investments|were held in non-cash investments|were held in non-cash investments|were held in non-cash investments||oroutside|
|---|---|---|---|---|---|---|---|---|---|---|
|ofthe UK. AII ofthe amounts||held in the current|account||are|available to spend on||charitable||activities.|
|18. Analysis
ofliabilities|||||||||||
|||||||2021||2020|||
|||||||f000||OOOO|||
|Creditors under
1year|||||||||||
|Trade creditors||||||10|||10||
|Other accruals||||||114|||51||
|||||||124|||61||
|Creditors falling due|after more than||1year||||||||
|Total||||||124|||||
|19. Reconciliation
of|net
income/(expenditure)|||||to net cash|flow|from|operating||
|activities|||||||||||
|||||||2021||||2020|
|||||||6'000||||F'000|
|Net
incomel(expenditure)
(as
Statement ofFinancial Activities)|||per|the||40||||(43)|
|Adjustments
for:|||||||||||
|(Gains)/losses
on investments|||||||||||
|(Purchase)/Sale
of Investments||||||42|||||
|Dividends,
interest and||rents from investments||||(2)||||(3)|
|(Increase)/decrease|in|debtors|||||||||
|Increase/(decrease)|in|creditors||||63||||35|
|Net cash
provided
activities||by (used in)|operating|||143||||(9)|
##
##
##
|||Balance|Income|Expenditure|Transfers|Balance|
|---|---|---|---|---|---|---|
|||b/f|||Gains/Losses|c/f|
|||K'000|F'000|K'000|R'000|E'000|
|Child Psychiatry||2||||2|
|Henderson
Staff Training||2||||2|
|Sutton
Community|Older|1||||1|
|People fund|||||||
|Crocus ward||||||10|
|Others (below 71k)||||||3|
|Total||17||||18|
|||||Balance
b/f|Income|Expenditure|Transfers
Gains/ Losses|Balance
c/f|
|---|---|---|---|---|---|---|---|---|
|||||K'000|E'000|8,'000|K'000|E'000|
|Aquarius||||9||||9|
|Deaf 8 Family|||||||||
|contingency|||||||||
|Pharmacy|MHU||||||||
|Richmond|Comm.||MH||||||
|team|||||||||
|Other designated||funds||||||12|
|General fund||||||(81)||40|
|Total||||37|120|(81)||76|
##
##
##
##
##